Antibiotic resistance is an approaching threat Olivia Lutz ’26, Columnist • April 1, 2026 The pharmaceutical industry is racing to meet demand for GLP-1 weight-loss drugs, such as Ozempic and Mounjaro, a market that JPMorgan forecasts will reach $200 billion by 2030. Meanwhile, the antibiotics...
